AOD-9604 is available from Kimerachems for controlled laboratory and analytical research. Review the product-specific information, available formats and documentation below before ordering.
AOD-9604
AOD-9604 is a synthetic peptide fragment derived from the human growth hormone (hGH) molecule. Specifically, it is identified as a modified hexadecapeptide corresponding to the C-terminal region (residues 177–191) with an additional N-terminal tyrosine residue added for enhanced structural stability. Researchers utilize this compound in laboratory models to investigate metabolic signaling pathways in isolated systems without activating canonical growth hormone receptor-mediated pathways. This structural selectivity makes AOD-9604 an essential research tool for exploring the molecular foundations of lipid metabolism, adipocyte receptor interactions, and somatotropic peptide dynamics.
Technical Specifications
| Property | Specification |
| Product Name | AOD-9604 |
| CAS Number | 221231-10-3 |
| IUPAC Name | L-tyrosyl-L-leucyl-L-arginyl-L-isoleucyl-L-valyl-L-glutaminyl-L-cysteinyl-L-arginyl-L-seryl-L-valyl-L-α-glutamyl-glycyl-L-seryl-L-cysteinyl-glycyl-L-phenylalanine (7→14)-disulfide |
| Molecular Formula | C₇₈H₁₂₃N₂₃O₂₃S₂ |
| Molecular Weight | 1815.1 g/mol |
| Chemical Class | Growth Hormone C-Terminal Peptide Fragment |
| Assay Purity | ≥99% (HPLC & CHN Verified) |
Research Applications & Mechanism of Interest
In controlled laboratory environments, AOD-9604 serves as a highly targeted ligand for metabolic signaling research. Its primary utility stems from its structural homology to the lipolytic domain of human growth hormone, allowing researchers to study specific metabolic pathways without the confounding variables associated with full-length growth hormone receptors.
Kimera Chems implements a strict dual-method verification protocol, combining High-Performance Liquid Chromatography (HPLC) with CHN elemental analysis to independently audit and verify both the molecular mass and absolute purity of our research compounds. This rigorous process ensures that the compound remains exceptionally stable, free from unwanted manufacturing byproducts, and performs consistently across a variety of experimental setups.
Primary fields of investigation include:
-
Adipocyte Receptor Studies: Investigating direct ligand binding profiles on isolated fat cells to map cellular pathway activations.
-
Metabolic Signaling Pathways: Evaluating the compound’s impact on lipolytic mechanisms and beta-3 adrenergic receptor-related pathways in vitro.
-
Receptor Binding Affinity: Assessing the selectivity of AOD-9604 for specific metabolic targets while documenting its lack of affinity for classical growth-promoting receptors.
-
Comparative Fragment Analysis: Benchmarking the molecule against other hGH-derived peptides and selective metabolic modulators to study structural efficiency.
-
Cell Culture Experiments: Analyzing biological responses within differentiated adipocyte cell culture lines to evaluate localized metabolic responses.
Storage & Handling Guidelines
To maintain molecular integrity and ensure consistent, reproducible results in analytical assays, researchers must adhere to precise laboratory storage guidelines:
-
Temperature Control: Store the solid-state compound at -20°C for long-term stabilization. For immediate, short-term laboratory use, storage at 2–8°C is appropriate.
-
Solution Maintenance: Once prepared in liquid assays or experimental solvent systems, samples should be strictly maintained at 2–8°C to prevent peptide hydrolysis.
-
Environmental Protections: Keep the compound completely shielded from moisture and direct UV light inside an airtight, opaque, or amber laboratory container.
Research Use Only Disclaimer: This product is distributed and sold strictly as a Research Use Only (RUO) compound. It is not a drug, licensed medication, food, or dietary supplement, and is strictly prohibited for human or veterinary consumption. Kimera Chems supplies these materials exclusively to qualified scientific institutions and professional investigators for use within controlled in vitro laboratory frameworks.
| CAS Number | 221231-10-3 |
| Other Names | Tyr-hgh frag 176-191, Anti obesity drug, hexadecapeptide AOD9604 |
| IUPAC Name | L-tyrosyl-L-leucyl-L-arginyl-L-isoleucyl-L-valyl-L-glutaminyl-L-cysteinyl-L-arginyl-L-seryl-L-valyl-L-alpha-glutamyl-glycyl-L-seryl-L-cysteinyl-glycyl-L-phenylalanine (7->14)-disulfide. |
| Molecular Formula | C78H123N23O23S2 |
| Molecular Weight | 1815.1 |
Product FAQs
What is AOD-9604 supplied for?
This material is supplied strictly for controlled, non-clinical laboratory and analytical research. It is not intended for human or animal consumption.
Which formats are available for AOD-9604?
The current listing shows these options: dry-fill-capsules-250mcg-60ct-15mg, peptide-5mg. Availability can change, so confirm the selector above before ordering.
Where can I review product documentation?
Where available, batch documentation can be reviewed in the Certificate of Analysis library before ordering.



